Print Icon
 
   

August 2021

Clinical Update: CAP Accreditation Inspection 

Genetics Institute of America is pleased to announce the successful completion of the College of American Pathologists (CAP) On-Site Inspection as a part of the accreditation cycle. 


The inspectors reported no deficiencies. 


During the rigorous peer-based inspection process, the inspector reviewed Genetic Institute’s comprehensive validations and protocols to ensure the highest quality and performance of the laboratory’s methods. 

The goal of maintaining this prestigious accreditation is to advance patient care and safety, while providing physicians and patients with the most accurate information possible.


“This successful CAP inspection validates our quality assurance and management practices, and ensures that we are providing the best in physician and patient-centered genetic testing services,” said Dr. Ana Perez-Miranda, Laboratory Manager for Genetics Institute of America.


Congratulations to Dr. Lourdes M. Trigo, Dr. Ana Perez-Miranda and their team here at Genetics Institute of America for their hard work and continued dedication to laboratory excellence.


   

Enroll your Practice in GH-101!


Genetics Institute of America is actively recruiting practices to join our study, GH-101! The objective of this study is to take an integrative approach to the fields of pharmacogenomics, cancer genomics, mRNA microarrays and nutrigenomics by identifying DNA and RNA variants in persons with chronic disease. We are looking for Physicians and Physician Groups that currently treat patients with a chronic disease including: cancer, cardiac conditions, diabetes, kidney disease, PTSD. Getting your practice involved is easy and not only gets patients the individualized health information they need but allows your practice to be on the cutting edge of genetic research. Click "Enroll Now" for more information about this study and enrolling your practice.


   

Have You Seen This? 

Rare Variants Indicate Higher Risk for Sudden Cardiac Death

   

More than 300,000 Americans suffer a sudden cardiac death every year with more than 10 percent remaining unexplained, even after an autopsy. 


A recent study discovered rare genetic variants were carried by almost 20 percent of patients that died from a sudden cardiac event.

It's All in the Genes:

Prescribing Anti-Platelet Therapy and CYP2C19

   

Genes are the key to understanding how a person metabolizes and activates many different types of medications. 


Pharmacogenetic testing can inform cardiologists and their patients what medications would be most beneficial in the treatment of cardiac conditions or post-procedure.

Changing Corporate Culture:

Ending Homelessness


Genetics Institute of America believes that it is our responsibility to care for the community we are a part of, and that corporate culture needs to change. Local communities are suffering and, without support from their businesses, will continue to decline and waste away in paralyzing cycles of homelessness, childhood trauma and hunger.

   
   
   

Thank you for the trust and confidence you have placed in our team here at the Genetics Institute of America. This monthly newsletter is our primary method of communicating to you important information about our testing and assays, general information about the Genetics Institute, as well as information impacting patient care and safety. If you would like to have another person in your practice receive these updates, please forward this to them so that they can subscribe.


   

Ana Perez-Miranda, PhD, MDxT (AAB), MB (ASCP)

Laboratory Manager and Molecular Diagnostics Supervisor

Genetics Institute of America

   

GIA Lab News is an educational service of Genetics Institute of America.


Genetics Institute of America is a national laboratory dedicated to heightening the awareness of early intervention and genetic screening to promote the longevity and quality of life outcomes. Our determination and research allow us to provide next generation DNA sequencing to deliver customized testing for identified genetic related cancers and other diseases.

Follow Us On

4733 W. Atlantic Ave, Suite C16

Delray Beach, FL 33445

Phone: (833) 4GENLAB or (833) 443-6522

HIPAA Fax: (561) 354-5369


You are receiving this email because you opted into receiving communications from Genetics Institute of America online or verbally on the phone, and/or maintain a professional relationship with our laboratory. From time to time, we’ll send newsletters, blog articles, and other educational clinical updates to our subscribers. We hope you find them useful. If not, you can unsubscribe from our list here.


Who do you know that needs to know? Forward this email

Did someone forward this to you? Subscribe

Want to change how you receive these emails?

You can Unsubscribe or Update your preferences


© 2021 Genetics Institute of America. All Rights Reserved.